ClinVar Miner

Submissions for variant NM_001846.4(COL4A2):c.3976G>A (p.Gly1326Arg)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV003148184 SCV003836084 uncertain significance Porencephaly 2 2022-11-22 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004554050 SCV004112680 uncertain significance COL4A2-related disorder 2023-08-04 criteria provided, single submitter clinical testing The COL4A2 c.3976G>A variant is predicted to result in the amino acid substitution p.Gly1326Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/13-111155566-G-A) and has been interpreted as uncertain in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/2441869/). This variant results in a glycine change within the conserved collagen triple helical domain (Gly-X-Y) where Gly changes are often expected to be pathogenic. However, no Gly changes have been previously reported at this residue or adjacent Gly residues (Human Gene Mutation Database). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.